Avail 30% Discount Now: Premium Insights at Discounted Price (Discount will be Applied at Checkout)

Global Duchenne Muscular Dystrophy Therapeutics Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

Segmented by Therapy Type;

Molecular-based Therapies - Mutation Suppression and Exon Skipping, Steroid Therapy - Corticosteroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Others.

Segmented by Distribution Channel;

Hospital Pharmacies, Retail Pharmacies and Online Pharmacies.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn371786367 Published Date: October, 2022 Updated Date: November, 2022

Introduction

Global Duchenne Muscular Dystrophy Therapeutics Market (USD Million), 2018 - 2028

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2018 - 2028
2018 92.5
2019 95.3
2020 96.1
2021 98.0
2022 98.3
2023 112.9
2024 125.6
2025 136.1
2026 137.7
2027 153.0
2028 179.7

In the year 2021, the Global Duchenne Muscular Dystrophy Therapeutics Market was valued at USD 7,354.68 million. The size of this market is expected to increase to USD 55,873.90 million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of 33.6%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Therapy Type
    2. Market Snapshot, By Distribution Channel
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global Duchenne Muscular Dystrophy Therapeutics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Disease Burden of Duchenne Muscular Dystrophy (DMD)
        2. Increasing Investments in Biopharmaceutical R&D to Release Novel Disease Therapies
        3. Increasing Awareness Campaigns for Duchenne Muscular Dystrophy (DMD)
      2. Restraints
        1. Stringent Regulatory Framework with High Product Cost Burden
        2. Lack of Standardization to Measure Clinical Efficacy Across All Stages of Duchenne Muscular Dystrophy (DMD)
      3. Opportunities
    2. Regulatory Scenario
    3. Pipeline Analysis/Technological Advancements
    4. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    5. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Duchenne Muscular Dystrophy Therapeutics Market, By Therapy Type, 2018 - 2028 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Molecular-based Therapies
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. Mutation Suppression
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Exon Skipping
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Steroid Therapy
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. Corticosteroids
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    2. Global Duchenne Muscular Dystrophy Therapeutics Market, By Distribution Channel, 2018 - 2028 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Hospital Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Retail Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Online Pharmacies
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    3. Global Duchenne Muscular Dystrophy Therapeutics Market, By Geography, 2018 - 2028 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
        4. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
        5. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2018 - 2028 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2028 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Bristol-Myers Squibb
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. BioMarin
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Fibrogen Inc
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Nobelpharma Co., Ltd
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. NS Pharma, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. Pfizer Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. PTC Therapeutics
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Santhera Pharmaceuticals
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      9. Sarepta Therapeutics
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      10. Eli Lilly and Company
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Medical Devices Durable Medical Equipment (DME)
Global Durable Medical Equipment (DME) Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Durable Medical Equipment (DME) Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Infectious Disorders
Global E. Coli Testing Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global E. Coli Testing Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Otorhinolaryngology (ENT)
Global Ear, Nose and Throat (ENT) Devices Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Ear, Nose and Throat (ENT) Devices Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Otorhinolaryngology (ENT)
Global Ear, Nose and Throat (ENT) Disorders Treatment Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Ear, Nose and Throat (ENT) Disorders Treatment Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...